TRAITEMENT DE LA FIBROSE PAR INHIBITION DE TL1A

• 收藏
• 分享

专利权人:

Cedars-Sinai Medical Center

发明人:

申请号：

EP19199149.6

公开号：

EP3639841A1

申请日:

2014.03.27

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The invention relates to methods of treating fibrosis and inflammatory bowel disease. In one embodiment, the present invention treats gut inflammation by administering a therapeutically effective dosage of TL1A inhibitors and/or DR3 inhibitors to an individual. In another embodiment, the present invention provides a method of reversing tissue fibrosis in an individual by inhibiting TL1A-DR3 signaling function.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/